329 related articles for article (PubMed ID: 37631339)
21. Conjugates of Tetrapyrrolic Macrocycles as Potential Anticancer Target-Oriented Photosensitizers.
Korolchuk AM; Zolottsev VA; Misharin AY
Top Curr Chem (Cham); 2023 Feb; 381(2):10. PubMed ID: 36826755
[TBL] [Abstract][Full Text] [Related]
22. AIE-Active Photosensitizers: Manipulation of Reactive Oxygen Species Generation and Applications in Photodynamic Therapy.
Yu H; Chen B; Huang H; He Z; Sun J; Wang G; Gu X; Tang BZ
Biosensors (Basel); 2022 May; 12(5):. PubMed ID: 35624649
[TBL] [Abstract][Full Text] [Related]
23. High Aspect Ratio Nanotubes Formed by Tobacco Mosaic Virus for Delivery of Photodynamic Agents Targeting Melanoma.
Lee KL; Carpenter BL; Wen AM; Ghiladi RA; Steinmetz NF
ACS Biomater Sci Eng; 2016 May; 2(5):838-844. PubMed ID: 28713855
[TBL] [Abstract][Full Text] [Related]
24. Efficiency of photodynamic therapy on WM35 melanoma with synthetic porphyrins: Role of chemical structure, intracellular targeting and antioxidant defense.
Baldea I; Olteanu DE; Bolfa P; Ion RM; Decea N; Cenariu M; Banciu M; Sesarman AV; Filip AG
J Photochem Photobiol B; 2015 Oct; 151():142-52. PubMed ID: 26257158
[TBL] [Abstract][Full Text] [Related]
25. The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy.
Li MY; Mi L; Meerovich G; Soe TW; Chen T; Than NN; Yan YJ; Chen ZL
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2335-2346. PubMed ID: 35522290
[TBL] [Abstract][Full Text] [Related]
26. Folic acid conjugates with photosensitizers for cancer targeting in photodynamic therapy: Synthesis and photophysical properties.
Stallivieri A; Colombeau L; Jetpisbayeva G; Moussaron A; Myrzakhmetov B; Arnoux P; Acherar S; Vanderesse R; Frochot C
Bioorg Med Chem; 2017 Jan; 25(1):1-10. PubMed ID: 27769669
[TBL] [Abstract][Full Text] [Related]
27. Janus macromolecular brushes for synergistic cascade-amplified photodynamic therapy and enhanced chemotherapy.
Tian J; Xiao C; Huang B; Wang C; Zhang W
Acta Biomater; 2020 Jan; 101():495-506. PubMed ID: 31726248
[TBL] [Abstract][Full Text] [Related]
28. Tetra-cationic platinum(II) porphyrins like a candidate photosensitizers to bind, selective and drug delivery for metastatic melanoma.
Couto GK; Pacheco BS; Borba VM; Junior JCR; Oliveira TL; Segatto NV; Seixas FK; Acunha TV; Iglesias BA; Collares T
J Photochem Photobiol B; 2020 Jan; 202():111725. PubMed ID: 31790880
[TBL] [Abstract][Full Text] [Related]
29. Tumor-specific activated photodynamic therapy with an oxidation-regulated strategy for enhancing anti-tumor efficacy.
Liang H; Zhou Z; Luo R; Sang M; Liu B; Sun M; Qu W; Feng F; Liu W
Theranostics; 2018; 8(18):5059-5071. PubMed ID: 30429886
[TBL] [Abstract][Full Text] [Related]
30. Upconversion nanoparticle-based optogenetic nanosystem for photodynamic therapy and cascade gene therapy.
Song X; Li F; Tian F; Ren L; Wang Q; Jiang C; Yan T; Zhang S
Acta Biomater; 2023 Feb; 157():538-550. PubMed ID: 36494007
[TBL] [Abstract][Full Text] [Related]
31. Phenylthiourea-Conjugated BODIPY as an Efficient Photosensitizer for Tyrosinase-Positive Melanoma-Targeted Photodynamic Therapy.
Jung E; Shim I; An J; Ji MS; Jangili P; Chi SG; Kim JS
ACS Appl Bio Mater; 2021 Mar; 4(3):2120-2127. PubMed ID: 35014340
[TBL] [Abstract][Full Text] [Related]
32. A novel pro-apoptotic role of zinc octacarboxyphthalocyanine in melanoma me45 cancer cell's photodynamic therapy (PDT).
Nackiewicz J; Kliber-Jasik M; Skonieczna M
J Photochem Photobiol B; 2019 Jan; 190():146-153. PubMed ID: 30551028
[TBL] [Abstract][Full Text] [Related]
33. Photophysical Characterization and in Vitro Phototoxicity Evaluation of 5,10,15,20-Tetra(quinolin-2-yl)porphyrin as a Potential Sensitizer for Photodynamic Therapy.
Costa LD; e Silva Jde A; Fonseca SM; Arranja CT; Urbano AM; Sobral AJ
Molecules; 2016 Mar; 21(4):439. PubMed ID: 27043519
[TBL] [Abstract][Full Text] [Related]
34. An insight on the role of photosensitizer nanocarriers for Photodynamic Therapy.
Mesquita MQ; Dias CJ; Gamelas S; Fardilha M; Neves MGPMS; Faustino MAF
An Acad Bras Cienc; 2018; 90(1 Suppl 2):1101-1130. PubMed ID: 29873674
[TBL] [Abstract][Full Text] [Related]
35. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.
Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T
Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235
[TBL] [Abstract][Full Text] [Related]
36. Lysosome-targeting phenalenones as efficient type I/II photosensitizers for anticancer photodynamic therapy.
Jiang Q; Li P; Qiu J; Li D; Li G; Shan G
Eur J Med Chem; 2023 Jul; 255():115418. PubMed ID: 37119664
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy efficacy enhanced by dynamics: the role of charge transfer and photostability in the selection of photosensitizers.
Arnaut LG; Pereira MM; Dąbrowski JM; Silva EF; Schaberle FA; Abreu AR; Rocha LB; Barsan MM; Urbańska K; Stochel G; Brett CM
Chemistry; 2014 Apr; 20(18):5346-57. PubMed ID: 24644142
[TBL] [Abstract][Full Text] [Related]
38. Porphyrin-related photosensitizers for cancer imaging and therapeutic applications.
Berg K; Selbo PK; Weyergang A; Dietze A; Prasmickaite L; Bonsted A; Engesaeter BØ; Angell-Petersen E; Warloe T; Frandsen N; Høgset A
J Microsc; 2005 May; 218(Pt 2):133-47. PubMed ID: 15857375
[TBL] [Abstract][Full Text] [Related]
39. Genotoxic potential of porphyrin type photosensitizers with particular emphasis on 5-aminolevulinic acid: implications for clinical photodynamic therapy.
Fuchs J; Weber S; Kaufmann R
Free Radic Biol Med; 2000 Feb; 28(4):537-48. PubMed ID: 10719235
[TBL] [Abstract][Full Text] [Related]
40. C-MYC and C-FOS expression changes and cellular aspects of the photodynamic reaction with photosensitizers TMPyP and ClAlPcS2.
Pizova K; Bajgar R; Fillerova R; Kriegova E; Cenklova V; Langova K; Konecny P; Kolarova H
J Photochem Photobiol B; 2015 Jan; 142():186-96. PubMed ID: 25545333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
